WASHINGTON, D.C.—The histologic changes that occur in patients with severe proliferative lupus nephritis following treatment with rituximab (Rituxan) plus cyclophosphamide may be seen, researchers say.
If patients could buy “negative outcome” insurance, the number of malpractice suits would decline dramatically, and the high cost of medical services would come down.
Autosomal dominant interstitial kidney disease is an under-recognized cause of kidney failure. Characterized by a very strong family history of kidney disease, it is a slowly progressive condition that leads to dialysis when patients are in their 40s or older.
WASHINGTON, D.C.—The best predictor of outcome in patients with lupus nephritis is kidney function at the time of renal biopsy, supporting the need for early diagnosis and treatment, researchers reported here at the American College of Rheumatology annual meeting.
The conventional wisdom used to be that apologizing to a patient was like talking to a cop: Anything you say can and will be used against you in a court of law.